体外式膜型人工肺（ECMO）装置市場規模、シェア、動向、2030年までの世界予測

体外式膜型人工肺（ECMO）装置市場 – 製品 [ECMO装置、コンポーネント（人工肺、ポンプ、コントローラー）]、モダリティ（静脈ECMOおよび動静脈ECMO）、患者タイプ（成人、新生児）、用途（呼吸器、心臓）、エンドユーザー（病院） – 2030年までの世界予測

体外式膜型人工肺（ECMO）装置市場は、予測期間中に 5.8% の CAGR で成長し、2025 年の 6 億 5,000 万米ドルから 2030 年までに 8 億 6,000 万米ドルに達すると予測されています。

近年、体外式膜型人工肺（ECMO）装置は、大型で手作業の多いシステムから、コンパクトで自動化された高効率プラットフォームへと進化しました。次世代ECMOは、リアルタイムモニタリング、自動流量調整、人工知能（AI）による酸素化制御を統合し、頻繁な手作業による介入の必要性を低減します。Getinge ABやMedtronicといった企業は、ポータブルECMOの革新をリードしており、病院間および病院内の患者搬送をよりスムーズにしています。一部のシステムは現在、ワイヤレス接続とクラウドベースのモニタリング機能を備えており、専門医が遠隔地の患者データを追跡できます。改良された遠心ポンプとポリメチルペンテン（PMP）製酸素化装置は耐久性を向上させ、溶血や血栓形成などの合併症を軽減します。さらに、抗凝固管理における革新は、ECMO患者にとって長年の課題であった出血リスクを軽減します。これらの技術革新は、患者の生存率を向上させ、スタッフの限られた病院にとってECMOをより使いやすくし、先進国および新興国のヘルスケア市場における普及を促進しています。

本レポートは、体外式膜型人工肺（ECMO）装置市場を評価し、製品、モダリティ、患者タイプ、用途、エンドユーザー、地域など、様々なセグメントに基づいて市場規模と将来の成長可能性を予測しています。また、主要企業の競合分析に加え、企業概要、製品ラインナップ、最近の動向、主要な市場戦略も掲載しています。

本レポートは、体外式膜型人工肺（ECMO）装置市場全体および各サブセグメントの収益数値の近似値に関するデータを提供し、市場リーダー／新規参入企業を支援します。また、ステークホルダーが競争環境を理解し、事業のポジショニングを改善し、適切な市場開拓戦略を策定するための洞察を深めるのに役立ちます。さらに、本レポートは、ステークホルダーが市場の動向を把握し、市場に影響を与える推進要因、阻害要因、障壁、そして機会に関するデータを提供するのに役立ちます。

Report Description

The ECMO machines market is projected to reach USD 0.86 billion by 2030 from USD 0.65 billion in 2025, at a CAGR of 5.8% during the forecast period.

In recent years, ECMO machines have evolved from bulky, manual-intensive systems to compact, automated, and highly efficient platforms. Next-generation ECMO integrates real-time monitoring, automated flow adjustments, and artificial intelligence (AI)-driven oxygenation control to reduce the need for constant manual intervention. Companies such as Getinge AB and Medtronic are leading in portable ECMO innovations, enabling smoother inter-hospital and intra-hospital patient transfers. Some systems now feature wireless connectivity and cloud-based monitoring, allowing specialists to track remote patient data. Improved centrifugal pumps and polymethyl pentene (PMP) oxygenators enhance durability and reduce complications such as hemolysis or clot formation. Moreover, innovations in anticoagulation management reduce the risks of bleeding, a historical challenge for ECMO patients. These technological leaps improve patient survival and make ECMO more user-friendly for hospitals with limited staff, driving wider adoption across developed and emerging healthcare markets.

Based on product, the market of ECMO machines is divided into components and ECMO machines. In 2024, the components segment held the largest share of the global ECMO machines market. With the rising incidence of acute respiratory distress syndrome (ARDS), cardiac arrest, and multi-organ failure, ECMO usage has expanded globally across tertiary hospitals. Each ECMO procedure consumes oxygenators, pumps, tubing sets, controllers, and cannulas. Even in short-term ECMO, components like oxygenators and cannulas are single-use, while pumps require precise compatibility and often get upgraded with each procedure. Post-pandemic preparedness further contributes to higher ECMO use, ensuring steady turnover of components. Unlike the machine itself, which remains constant, the increasing number of procedures fuels exponential growth in the component segment.

Based on patient type, the ECMO market has been categorized into adults, pediatrics and neonates. In 2024, adults held the largest market share in the ECMO machines market. The COVID-19 pandemic highlighted ECMO’s role in treating severe respiratory failure in adults. During the peak, most ECMO-supported cases were adults with severe ARDS. Even after the acute pandemic phase, many survivors experienced long-term pulmonary damage, fibrosis, and other respiratory complications that increased ECMO utilization in critical cases. Post-COVID-19 complications like myocarditis and post-viral pneumonia also primarily affect adults, contributing to higher demand for ECMO in this age group. Hospitals worldwide expanded ECMO infrastructure during the pandemic, with a focus on adult ICUs, leaving a long-term impact on equipment adoption. This legacy effect ensured that adults continued to account for the largest ECMO market share in 2024.

North America is expected to account for the largest share of the ECMO machines market during the forecast period. North America, particularly the US and Canada, benefits from a highly advanced healthcare ecosystem equipped with top-tier hospitals, critical care units, and specialized medical centers. These facilities can support sophisticated and resource-intensive technologies such as ECMO. Large tertiary hospitals and academic medical centers often serve as hubs for ECMO procedures, offering advanced ICUs and trained multidisciplinary teams that ensure effective patient management. In contrast to emerging regions, North American hospitals possess the financial and infrastructural capacity to invest in expensive ECMO equipment and maintain it efficiently. Furthermore, strong integration of digital health systems, including advanced monitoring tools, ensures safe ECMO management. This infrastructure readiness makes it feasible for ECMO adoption at scale, enhancing accessibility and increasing survival outcomes. As a result, the well-developed healthcare network plays a central role in reinforcing North America’s leadership in the ECMO machines market.

A breakdown of the primary participants (supply-side) for the ECMO machines market referred to in this report is provided below:

• By Company Type: Tier 1: 34%, Tier 2: 38%, and Tier 3: 28%
• By Designation: C Level: 26%, Director Level: 35%, and Others: 39%
• By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5%

Prominent players in the ECMO machines market are Fresenius Medical Care AG & Co. KGaA (Germany), Getinge AB (Sweden), Medtronic (Ireland), Terumo Corporation (Japan), and LivaNova PLC (UK).

Research Coverage

The report evaluates the ECMO machines market and estimates the market size and future growth potential based on various segments, including product, modality, patient type, application, end user, and region. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will assist the market leader/new entrants with data on the nearest approximations of the revenue numbers for the overall ECMO machines market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better positioning their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market.

This report provides insights into the following points:

Analysis of key drivers (Increasing prevalence of cardiovascular and respiratory diseases, Growing adoption of ECMO in lung transplantation procedures), restraints (Complications associated with ECMO, High cost of ECMO procedures), opportunities (Increasing survival rates with ECMO), and challenges (Shortage of skilled professionals, Eligibility issues for ECMO)

• Product Launches/Innovations: Comprehensive details about product launches and anticipated trends in the global ECMO machines market
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product, modality, patient type, application, end user, and region
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ECMO machines market
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ECMO machines market

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           STUDY SCOPE   26

1.3.1        MARKET SEGMENTATION AND REGIONAL SCOPE                 26

1.3.2        INCLUSIONS AND EXCLUSIONS 27

1.3.3        YEARS CONSIDERED      28

1.4           CURRENCY CONSIDERED            28

1.5           STAKEHOLDERS               29

1.6           SUMMARY OF CHANGES               29

2               RESEARCH METHODOLOGY       31

2.1           RESEARCH DATA              31

2.1.1        SECONDARY DATA          32

2.1.1.1    Key data from secondary sources       33

2.1.2        PRIMARY DATA 33

2.1.2.1    Key data from primary sources           34

2.1.2.2    Key industry insights           35

2.2           MARKET SIZE ESTIMATION         37

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 42

2.4           MARKET SHARE ESTIMATION    43

2.5           RESEARCH ASSUMPTIONS           44

2.6           RESEARCH LIMITATIONS             44

2.7           RISK ASSESSMENT           44

3               EXECUTIVE SUMMARY  45

4               PREMIUM INSIGHTS       49

4.1           ECMO MACHINES MARKET OVERVIEW 49

4.2           ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT AND COUNTRY (2024)    50

4.3           ECMO MACHINES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              51

4.4           ECMO MACHINES MARKET, REGIONAL MIX, 2023−2030                 51

4.5           ECMO MACHINES MARKET: EMERGING VS. DEVELOPED ECONOMIES      52

5               MARKET OVERVIEW       53

5.1           INTRODUCTION              53

5.2           MARKET DYNAMICS       53

5.2.1        DRIVERS               54

5.2.1.1    Increasing prevalence of cardiovascular and respiratory diseases                 54

5.2.1.2    Growing adoption of ECMO in lung transplantation procedures                 55

5.2.1.3    Rise in ECMO centers worldwide      55

5.2.1.4    Technological advancements in ECMO machines          55

5.2.2        RESTRAINTS      56

5.2.2.1    Complications associated with ECMO              56

5.2.2.2    High cost of ECMO procedures         56

5.2.3        OPPORTUNITIES              57

5.2.3.1    Increasing survival rates with ECMO                57

5.2.4        CHALLENGES    57

5.2.4.1    Shortage of skilled professionals        57

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       57

5.4           PRICING ANALYSIS          58

5.4.1        AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE                 58

5.4.2        AVERAGE SELLING PRICE TREND, BY REGION   59

5.5           VALUE CHAIN ANALYSIS               60

5.6           SUPPLY CHAIN ANALYSIS             62

5.7           ECOSYSTEM ANALYSIS  63

5.8           INVESTMENT AND FUNDING SCENARIO               65

5.9           TECHNOLOGY ANALYSIS             66

5.9.1        KEY TECHNOLOGIES     66

5.9.1.1    Advanced oxygenator design              66

5.9.1.2    High-efficiency blood pumps              67

5.9.2        COMPLEMENTARY TECHNOLOGIES       67

5.9.2.1    Advanced hemodynamic monitoring systems  67

5.9.2.2    Ventilators             67

5.9.3        ADJACENT TECHNOLOGIES       68

5.9.3.1    Wearable Artificial Lungs (WALs)    68

5.9.3.2    Perfusion systems 68

5.10         INDUSTRY TRENDS         69

5.10.1      GROWING ADOPTION OF ECMO IN NON-TRADITIONAL CARE SETTINGS                69

5.10.2      INCREASING USE OF ECMO IN PEDIATRIC AND NEONATAL CARE             69

5.10.3      SHIFT TOWARD ECMO CENTERS OF EXCELLENCE AND REGIONALIZATION        69

5.10.4      GROWTH OF ECMO SIMULATION TRAINING AND TELE-ECMO PROGRAMS           70

5.11         PATENT ANALYSIS          70

5.12         TRADE ANALYSIS             71

5.12.1      IMPORT DATA FOR HS CODE 901890       71

5.12.2      EXPORT DATA FOR HS CODE 901890       72

5.13         KEY CONFERENCES AND EVENTS, 2025–2026        73

5.14         CASE STUDY ANALYSIS 74

5.14.1      CASE STUDY 1: IMPROVED SURVIVAL RATES IN US USING ECMO     74

5.14.2      CASE STUDY 2: NEONATAL ECMO PROGRAM IN UK                 74

5.14.3      CASE STUDY 3: MOBILE ECMO TRANSPORT SERVICE IN GERMANY           74

5.15         REGULATORY LANDSCAPE         75

5.15.1      REGULATORY ANALYSIS               75

5.15.1.1  North America      75

5.15.1.1.1                US           75

5.15.1.1.2                Canada   75

5.15.1.2  Europe   75

5.15.1.2.1                Germany                 75

5.15.1.2.2                France    76

5.15.1.2.3                UK          76

5.15.1.3  Asia Pacific            76

5.15.1.3.1                China      76

5.15.1.3.2                Japan      77

5.15.1.3.3                India       77

5.15.1.4  Latin America       77

5.15.1.4.1                Brazil      77

5.15.1.4.2                Mexico   78

5.15.1.5  Middle East & Africa            78

5.15.1.5.1                South Africa           78

5.15.1.5.2                GCC Countries     78

5.15.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             79

5.16         PORTER’S FIVE FORCES ANALYSIS           81

5.16.1      BARGAINING POWER OF SUPPLIERS       82

5.16.2      BARGAINING POWER OF BUYERS             82

5.16.3      THREAT OF NEW ENTRANTS      82

5.16.4      THREAT OF SUBSTITUTES          83

5.16.5      INTENSITY OF COMPETITIVE RIVALRY 83

5.17         KEY STAKEHOLDERS AND BUYING CRITERIA     83

5.17.1      KEY STAKEHOLDERS IN BUYING PROCESS           83

5.17.2      BUYING CRITERIA           84

5.18         UNMET NEEDS/END-USER EXPECTATIONS         85

5.19         ADJACENT MARKET ANALYSIS  85

5.20         IMPACT OF AI/GEN AI ON ECMO MACHINES MARKET                 86

5.20.1      INTRODUCTION              86

5.20.2      MARKET POTENTIAL OF GEN AI ON ECMO MACHINES MARKET               86

5.20.3      AI USE CASES     87

5.20.4      KEY COMPANIES IMPLEMENTING AI      87

5.20.5      FUTURE OF GEN AI IN ECMO MACHINES MARKET                 88

5.21         IMPACT OF 2025 US TARIFF ON ECMO MACHINES MARKET               88

5.21.1      KEY TARIFF RATES          89

5.21.2      PRICE IMPACT ANALYSIS             90

5.21.3      KEY IMPACT ON COUNTRY/REGION      90

5.21.3.1  US           90

5.21.3.2  Europe   90

5.21.3.3  Asia Pacific            91

5.21.4      IMPACT ON END-USE INDUSTRIES          91

6               ECMO MACHINES MARKET, BY PRODUCT            92

6.1           INTRODUCTION              93

6.2           COMPONENTS  93

6.2.1        OXYGENATORS 94

6.2.1.1    Significantly less priming volume associated with PMP oxygenators to boost demand             94

6.2.2        PUMPS 96

6.2.2.1    Pivotal role played by centrifugal blood pumps in adult extracorporeal life support to support market growth    96

6.2.3        CONTROLLERS 97

6.2.3.1    Ability of controllers to allow operators of ECMO circuits to adjust settings as needed to drive demand       97

6.2.4        CANNULAS         98

6.2.4.1    Importance of cannulas in optimizing ECMO flows to boost market    98

6.2.5        ACCESSORIES    99

6.3           MACHINES          101

6.3.1        ADVANTAGES SUCH AS TIMELY INTERVENTION IN CASES OF RESPIRATORY AND CARDIAC EMERGENCIES TO FUEL GROWTH             101

7               ECMO MACHINES MARKET, BY MODALITY          103

7.1           INTRODUCTION              104

7.2           VENOVENOUS ECMO     104

7.2.1        LOWER INCIDENCE OF NEUROLOGIC COMPLICATIONS AND LACK OF ARTERIAL COMPROMISE TO BOOST GROWTH                 104

7.3           VENOARTERIAL ECMO  105

7.3.1        INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE GROWTH               105

7.4           ARTERIOVENOUS ECMO               106

7.4.1        PORTABILITY OF ARTERIOVENOUS ECMO MACHINES TO DRIVE DEMAND        106

8               ECMO MACHINES MARKET, BY PATIENT TYPE  108

8.1           INTRODUCTION              109

8.2           ADULT PATIENTS            110

8.2.1        TECHNOLOGICAL ADVANCEMENTS TO DRIVE USE OF ECMO IN ADULT PATIENTS        110

8.3           PEDIATRIC PATIENTS   111

8.3.1        RECENT ADVANCES IN ECMO TO BOOST MARKET GROWTH             111

8.4           NEONATES         112

8.4.1        INCREASING UTILIZATION OF ECMO TO MANAGE NEONATES WITH CARDIAC AND RESPIRATORY FAILURE TO SUPPORT GROWTH        112

9               ECMO MACHINES MARKET, BY APPLICATION    113

9.1           INTRODUCTION              114

9.2           RESPIRATORY APPLICATIONS   114

9.2.1        INCREASING CASES OF ACUTE RESPIRATORY DISTRESS

SYNDROME, PNEUMONIA, AND INFLUENZA TO SPUR GROWTH                 114

9.3           CARDIAC APPLICATIONS             115

9.3.1        RISING PREVALENCE OF CARDIOVASCULAR DISEASES WORLDWIDE TO SUPPORT GROWTH    115

9.4           EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION              116

9.4.1        GROWING CLINICAL EVIDENCE SUGGESTING IMPROVED SURVIVAL RATES AND NEUROLOGICAL OUTCOMES TO FUEL MARKET            116

10            ECMO MACHINES MARKET, BY END USER            118

10.1         INTRODUCTION              119

10.2         HOSPITALS         119

10.2.1      GROWING USE OF ECMO FOR MANAGING CRITICAL CONDITIONS

TO DRIVE MARKET         119

10.3         ACADEMIC & RESEARCH INSTITUTIONS               120

10.3.1      INCREASING MEDICAL COLLEGES AND RESEARCH FACILITIES INVESTING IN ECMO SYSTEMS TO FOSTER GROWTH             120

10.4         SPECIALTY CLINICS        121

10.4.1      RISING NEED FOR ADVANCED, LIFE-SAVING INTERVENTIONS TO AID GROWTH         121

11            ECMO MACHINES MARKET, BY REGION                 123

11.1         INTRODUCTION              124

11.2         NORTH AMERICA             124

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 124

11.2.2      US           128

11.2.2.1  US to account for largest share of North American market                 128

11.2.3      CANADA               130

11.2.3.1  Implementation of ABF model in Canadian hospitals to drive market growth       130

11.3         EUROPE               133

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      133

11.3.2      GERMANY           135

11.3.2.1  Increasing volume of ECMO procedures to drive market growth in Germany            135

11.3.3      FRANCE                138

11.3.3.1  Rising healthcare spending to drive market growth in France                 138

11.3.4      UK          140

11.3.4.1  Significant investment in healthcare to support adoption of advanced medical technologies like ECMO     140

11.3.5      ITALY    143

11.3.5.1  High burden of CVDs to contribute to growth of ECMO machines market in Italy     143

11.3.6      SPAIN    145

11.3.6.1  High adoption of advanced technologies to drive market growth in Spain  145

11.3.7      REST OF EUROPE             148

11.4         ASIA PACIFIC     149

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 150

11.4.2      JAPAN   153

11.4.2.1  Favorable healthcare infrastructure in Japan to drive market growth    153

11.4.3      CHINA  156

11.4.3.1  Large patient population and government-backed critical care infrastructure expansion to fuel growth            156

11.4.4      INDIA    158

11.4.4.1  Growing applications and rising adoption of ECMO to drive market growth in India        158

11.4.5      SOUTH KOREA  161

11.4.5.1  Advanced healthcare infrastructure and early ECMO adoption to position South Korea as leading regional market             161

11.4.6      AUSTRALIA         163

11.4.6.1  Rising respiratory and cardiac complications, coupled with aging population, to fuel ECMO adoption  163

11.4.7      REST OF ASIA PACIFIC   165

11.5         LATIN AMERICA                168

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 168

11.5.2      BRAZIL 171

11.5.2.1  Rising adoption of ECMO as bridge to heart and lung transplantation to drive market growth in Brazil             171

11.5.3      MEXICO                173

11.5.3.1  High burden of CVDs in country to drive market growth in Mexico   173

11.5.4      REST OF LATIN AMERICA             175

11.6         MIDDLE EAST & AFRICA                178

11.6.1      INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH IN MIDDLE EAST & AFRICA    178

11.6.2      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 178

11.7         GCC COUNTRIES              180

11.7.1      RISING INVESTMENTS IN ADVANCED HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH       180

11.7.2      MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 181

12            COMPETITIVE LANDSCAPE         184

12.1         OVERVIEW          184

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            184

12.3         REVENUE ANALYSIS, 2020–2024  186

12.4         MARKET SHARE ANALYSIS, 2024                 187

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 188

12.5.1      STARS   188

12.5.2      EMERGING LEADERS     188

12.5.3      PERVASIVE PLAYERS      189

12.5.4      PARTICIPANTS 189

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         190

12.5.5.1  Company footprint               190

12.5.5.2  Region footprint   191

12.5.5.3  Product footprint  191

12.5.5.4  Application footprint            192

12.5.5.5  End-user footprint                192

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        193

12.6.1      PROGRESSIVE COMPANIES         193

12.6.2      RESPONSIVE COMPANIES            193

12.6.3      DYNAMIC COMPANIES  193

12.6.4      STARTING BLOCKS         193

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 195

12.6.5.1  Detailed list of key startups/SMEs    195

12.6.5.2  Competitive benchmarking of startups/SMEs 195

12.7         COMPANY VALUATION & FINANCIAL METRICS 196

12.7.1      FINANCIAL METRICS      196

12.7.2      COMPANY VALUATION 196

12.8         BRAND/PRODUCT COMPARISON             197

12.9         COMPETITIVE SCENARIO             198

12.9.1      PRODUCT LAUNCHES & APPROVALS     198

12.9.2      DEALS  199

12.9.3      EXPANSIONS     199

13            COMPANY PROFILES      200

13.1         KEY PLAYERS     200

13.1.1      GETINGE             200

13.1.1.1  Business overview 200

13.1.1.2  Products offered   201

13.1.1.3  Recent developments           202

13.1.1.3.1                Product launches  202

13.1.1.3.2                Expansions             202

13.1.1.4  MnM view              203

13.1.1.4.1                Right to win           203

13.1.1.4.2                Strategic choices   203

13.1.1.4.3                Weaknesses & competitive threats     203

13.1.2      MEDTRONIC      204

13.1.2.1  Business overview 204

13.1.2.2  Products offered   206

13.1.2.3  MnM view              206

13.1.2.3.1                Right to win           206

13.1.2.3.2                Strategic choices   206

13.1.2.3.3                Weaknesses & competitive threats     207

13.1.3      TERUMO CORPORATION             208

13.1.3.1  Business overview 208

13.1.3.2  Products offered   210

13.1.3.3  Recent developments           210

13.1.3.3.1                Deals      210

13.1.3.3.2                Expansions             211

13.1.3.4  MnM view              211

13.1.3.4.1                Right to win           211

13.1.3.4.2                Strategic choices   211

13.1.3.4.3                Weaknesses & competitive threats     211

13.1.4      FRESENIUS MEDICAL CARE AG  212

13.1.4.1  Business overview 212

13.1.4.2  Products offered   213

13.1.4.3  Recent developments           214

13.1.4.3.1                Deals      214

13.1.4.4  MnM view              214

13.1.4.4.1                Right to win           214

13.1.4.4.2                Strategic choices   214

13.1.4.4.3                Weaknesses & competitive threats     214

13.1.5      LIVANOVA PLC 215

13.1.5.1  Business overview 215

13.1.5.2  Products offered   217

13.1.5.3  MnM view              217

13.1.5.3.1                Right to win           217

13.1.5.3.2                Strategic choices   217

13.1.5.3.3                Weaknesses & competitive threats     218

13.1.6      NIPRO   219

13.1.6.1  Business overview 219

13.1.6.2  Products offered   220

13.1.7      WEIGAO GROUP CO., LTD.          221

13.1.7.1  Business overview 221

13.1.7.2  Products offered   223

13.1.8      ABBOTT               224

13.1.8.1  Business overview 224

13.1.8.2  Products offered   225

13.1.8.3  Recent developments           226

13.1.8.3.1                Product approvals 226

13.1.9      MICROPORT SCIENTIFIC CORPORATION             227

13.1.9.1  Business overview 227

13.1.9.2  Products offered   228

13.1.10   EUROSETS          229

13.1.10.1                 Business overview 229

13.1.10.2                 Products offered   229

13.2         OTHER PLAYERS              230

13.2.1      SPECTRUM MEDICAL     230

13.2.2      SENKO MEDICAL INSTRUMENT MFG. CO., LTD.                 231

13.2.3      CHALICE MEDICAL LTD.               232

13.2.4      MAGASSIST CO., LTD.    233

13.2.5      BRAILE BIOMÉDICA       234

13.2.6      GIZMOMED PRIVATE LIMITED 235

13.2.7      ORIGEN BIOMEDICAL, INC.         236

13.2.8      ABIOMED            236

13.2.9      ANDOCOR           237

13.2.10   JIANGSU STMED TECHNOLOGY CO., LTD.           238

13.2.11   CARDIOQUIP     238

13.2.12   CBM LIFEMOTION           239

13.2.13   CHANGZHOU KANGXIN MEDICAL INSTRUMENTS                 240

13.2.14   GENTHERM        241

14            APPENDIX           242

14.1         DISCUSSION GUIDE        242

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                248

14.3         CUSTOMIZATION OPTIONS        250

14.4         RELATED REPORTS         250

14.5         AUTHOR DETAILS           251

LIST OF TABLES

TABLE 1                ECMO MACHINES MARKET: INCLUSIONS AND EXCLUSIONS      27

TABLE 2                STANDARD CURRENCY CONVERSION RATES, 2020–2024              28

TABLE 3                ECMO MACHINES MARKET: RISK ASSESSMENT                 44

TABLE 4                ECMO MACHINES MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS                54

TABLE 5                AVERAGE COST OF ECMO, BY COUNTRY, 2024 (USD)    56

TABLE 6                AVERAGE SELLING PRICE OF KEY PLAYERS, BY TYPE, 2024 (USD)              58

TABLE 7                AVERAGE SELLING PRICE TREND OF ECMO MACHINES, BY REGION,

2022–2024 (USD)                59

TABLE 8                ECMO MACHINES MARKET: ROLE OF COMPANIES IN ECOSYSTEM       64

TABLE 9                IMPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND)      71

TABLE 10              EXPORT DATA FOR HS CODE 901890-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND)      72

TABLE 11              ECMO MACHINES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026                 73

TABLE 12              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 13              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  79

TABLE 14              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 15              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 16              REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  80

TABLE 17              ECMO MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS           82

TABLE 18              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS (%) 84

TABLE 19              KEY BUYING CRITERIA FOR TOP TWO PRODUCTS         84

TABLE 20              US-ADJUSTED RECIPROCAL TARIFF RATES                 89

TABLE 21              KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ECMO MACHINES  89

TABLE 22              ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)       93

TABLE 23              COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 93

TABLE 24              COMPONENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       94

TABLE 25              EXAMPLES OF OXYGENATORS  95

TABLE 26              OXYGENATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       95

TABLE 27              EXAMPLES OF PUMPS    96

TABLE 28              PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            96

TABLE 29              EXAMPLES OF CONTROLLERS   97

TABLE 30              CONTROLLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       97

TABLE 31              EXAMPLES OF CANNULAS            98

TABLE 32              CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99

TABLE 33              EXAMPLES OF ACCESSORIES      100

TABLE 34              ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100

TABLE 35              EXAMPLES OF MACHINES            101

TABLE 36              MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102

TABLE 37              MACHINES MARKET, BY REGION, 2023–2030 (UNITS)                102

TABLE 38              ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)            104

TABLE 39              VENOVENOUS ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            105

TABLE 40              VENOARTERIAL ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 41              ARTERIOVENOUS ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            107

TABLE 42              COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC PATIENTS,

AND ADULT PATIENTS 109

TABLE 43              ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)            109

TABLE 44              ECMO MACHINES MARKET FOR ADULT PATIENTS, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 45              ECMO MACHINES MARKET FOR PEDIATRIC PATIENTS, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 46              ECMO MACHINES MARKET FOR NEONATES, BY COUNTRY,

2023–2030 (USD MILLION)            112

TABLE 47              ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            114

TABLE 48              ECMO MACHINES MARKET FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)                 115

TABLE 49              ECMO MACHINES MARKET FOR CARDIAC APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 50              ECMO MACHINES MARKET FOR EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2023–2030 (USD MILLION)     117

TABLE 51              ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)       119

TABLE 52              ECMO MACHINES MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 53              ECMO MACHINES MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS,

BY COUNTRY, 2023–2030 (USD MILLION)               121

TABLE 54              ECMO MACHINES MARKET FOR SPECIALTY CLINICS, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 55              ECMO MACHINES MARKET, BY REGION, 2023–2030 (USD MILLION)       124

TABLE 56              NORTH AMERICA: ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            125

TABLE 57              NORTH AMERICA: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            126

TABLE 58              NORTH AMERICA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                126

TABLE 59              NORTH AMERICA: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            126

TABLE 60              NORTH AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            127

TABLE 61              NORTH AMERICA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            127

TABLE 62              NORTH AMERICA: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            127

TABLE 63              US: MACROECONOMIC INDICATORS      128

TABLE 64              US: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            128

TABLE 65              US: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129

TABLE 66              US: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)            129

TABLE 67              US: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                129

TABLE 68              US: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              130

TABLE 69              US: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)            130

TABLE 70              CANADA: MACROECONOMIC INDICATORS                 131

TABLE 71              CANADA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     131

TABLE 72              CANADA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            131

TABLE 73              CANADA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   131

TABLE 74              CANADA: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            132

TABLE 75              CANADA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              132

TABLE 76              CANADA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                132

TABLE 77              EUROPE: ECMO MACHINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     133

TABLE 78              EUROPE: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     134

TABLE 79              EUROPE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            134

TABLE 80              EUROPE: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   134

TABLE 81              EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            134

TABLE 82              EUROPE: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              135

TABLE 83              EUROPE: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                135

TABLE 84              GERMANY: MACROECONOMIC INDICATORS                 136

TABLE 85              GERMANY: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     136

TABLE 86              GERMANY: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            136

TABLE 87              GERMANY: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   137

TABLE 88              GERMANY: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            137

TABLE 89              GERMANY: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            137

TABLE 90              GERMANY: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                138

TABLE 91              FRANCE: MACROECONOMIC INDICATORS                 138

TABLE 92              FRANCE: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     138

TABLE 93              FRANCE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            139

TABLE 94              FRANCE: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   139

TABLE 95              FRANCE: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            139

TABLE 96              FRANCE: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              140

TABLE 97              FRANCE: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                140

TABLE 98              UK: MACROECONOMIC INDICATORS     141

TABLE 99              UK: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)            141

TABLE 100            UK: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141

TABLE 101            UK: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)            141

TABLE 102            UK: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                142

TABLE 103            UK: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              142

TABLE 104            UK: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)            142

TABLE 105            ITALY: MACROECONOMIC INDICATORS                 143

TABLE 106            ITALY: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     143

TABLE 107            ITALY: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       144

TABLE 108            ITALY: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   144

TABLE 109            ITALY: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                144

TABLE 110            ITALY: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              145

TABLE 111            ITALY: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                145

TABLE 112            SPAIN: MACROECONOMIC INDICATORS                 146

TABLE 113            SPAIN: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     146

TABLE 114            SPAIN: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       146

TABLE 115            SPAIN: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   146

TABLE 116            SPAIN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                147

TABLE 117            SPAIN: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              147

TABLE 118            SPAIN: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                147

TABLE 119            REST OF EUROPE: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            148

TABLE 120            REST OF EUROPE: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                148

TABLE 121            REST OF EUROPE: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            148

TABLE 122            REST OF EUROPE: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            149

TABLE 123            REST OF EUROPE: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            149

TABLE 124            REST OF EUROPE: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            149

TABLE 125            ASIA PACIFIC: ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 126            ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            151

TABLE 127          ASIA PACIFIC: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            151

TABLE 128            ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            152

TABLE 129            ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            152

TABLE 130            ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            152

TABLE 131            ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            153

TABLE 132            JAPAN: MACROECONOMIC INDICATORS                 153

TABLE 133            JAPAN: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     154

TABLE 134            JAPAN: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       154

TABLE 135            JAPAN: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   154

TABLE 136            JAPAN: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                155

TABLE 137            JAPAN: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              155

TABLE 138            JAPAN: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                155

TABLE 139            CHINA: MACROECONOMIC INDICATORS                 156

TABLE 140            CHINA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     156

TABLE 141            CHINA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       157

TABLE 142            CHINA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   157

TABLE 143            CHINA: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)                157

TABLE 144            CHINA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              158

TABLE 145            CHINA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                158

TABLE 146            INDIA: MACROECONOMIC INDICATORS                 158

TABLE 147            INDIA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     159

TABLE 148            INDIA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       159

TABLE 149            INDIA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   159

TABLE 150            INDIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023–2030 (USD MILLION)                160

TABLE 151            INDIA: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              160

TABLE 152            INDIA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                160

TABLE 153            SOUTH KOREA: MACROECONOMIC INDICATORS      161

TABLE 154            SOUTH KOREA: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            161

TABLE 155            SOUTH KOREA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                162

TABLE 156            SOUTH KOREA: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            162

TABLE 157            SOUTH KOREA: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            162

TABLE 158            SOUTH KOREA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            163

TABLE 159            SOUTH KOREA: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 160            AUSTRALIA: MACROECONOMIC INDICATORS                 164

TABLE 161            AUSTRALIA: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     164

TABLE 162            AUSTRALIA: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            164

TABLE 163            AUSTRALIA: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   164

TABLE 164            AUSTRALIA: ECMO MACHINES MARKET, PATIENT TYPE, 2023–2030 (USD MILLION)            165

TABLE 165            AUSTRALIA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            165

TABLE 166            AUSTRALIA: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                165

TABLE 167            REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            166

TABLE 168            REST OF ASIA PACIFIC: COMPONENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            166

TABLE 169            REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            166

TABLE 170            REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            167

TABLE 171            REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            167

TABLE 172            REST OF ASIA PACIFIC: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            167

TABLE 173            LATIN AMERICA: ECMO MACHINES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            168

TABLE 174            LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            169

TABLE 175            LATIN AMERICA: COMPONENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            169

TABLE 176            LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            169

TABLE 177            LATIN AMERICA: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            170

TABLE 178            LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            170

TABLE 179            LATIN AMERICA: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            170

TABLE 180            BRAZIL: MACROECONOMIC INDICATORS                 171

TABLE 181            BRAZIL: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     171

TABLE 182            BRAZIL: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)       172

TABLE 183            BRAZIL: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   172

TABLE 184            BRAZIL: ECMO MACHINES MARKET, BY PATIENT TYPE, 2023–2030 (USD MILLION)            172

TABLE 185            BRAZIL: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              173

TABLE 186            BRAZIL: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                173

TABLE 187            MEXICO: MACROECONOMIC INDICATORS                 174

TABLE 188            MEXICO: ECMO MACHINES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     174

TABLE 189            MEXICO: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)            174

TABLE 190            MEXICO: ECMO MACHINES MARKET, BY MODALITY, 2023–2030 (USD MILLION)   174

TABLE 191            MEXICO: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            175

TABLE 192            MEXICO: ECMO MACHINES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              175

TABLE 193            MEXICO: ECMO MACHINES MARKET, BY END USER, 2023–2030 (USD MILLION)                175

TABLE 194            REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            176

TABLE 195            REST OF LATIN AMERICA: COMPONENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            176

TABLE 196            REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            176

TABLE 197            REST OF LATIN AMERICA: ECMO MACHINES MARKET, PATIENT TYPE,

2023–2030 (USD MILLION)            177

TABLE 198            REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            177

TABLE 199            REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            177

TABLE 200            MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            178

TABLE 201            MIDDLE EAST & AFRICA: COMPONENTS MARKET, BY TYPE,

2023–2030 (USD MILLION)            179

TABLE 202            MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            179

TABLE 203            MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            179

TABLE 204            MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            180

TABLE 205            MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            180

TABLE 206            GCC COUNTRIES: ECMO MACHINES MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            181

TABLE 207            GCC COUNTRIES: COMPONENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)                181

TABLE 208            GCC COUNTRIES: ECMO MACHINES MARKET, BY MODALITY,

2023–2030 (USD MILLION)            182

TABLE 209            GCC COUNTRIES: ECMO MACHINES MARKET, BY PATIENT TYPE,

2023–2030 (USD MILLION)            182

TABLE 210            GCC COUNTRIES: ECMO MACHINES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            182

TABLE 211            GCC COUNTRIES: ECMO MACHINES MARKET, BY END USER,

2023–2030 (USD MILLION)            183

TABLE 212            KEY DEVELOPMENTS IN ECMO MACHINES MARKET,

JANUARY 2021–SEPTEMBER 2025                184

TABLE 213            ECMO MACHINES MARKET: DEGREE OF COMPETITION 187

TABLE 214            ECMO MACHINES MARKET: REGION FOOTPRINT       191

TABLE 215            ECMO MACHINES MARKET: PRODUCT FOOTPRINT       191

TABLE 216            ECMO MACHINES MARKET: APPLICATION FOOTPRINT       192

TABLE 217            ECMO MACHINES MARKET: END-USER FOOTPRINT       192

TABLE 218            ECMO MACHINES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS    195

TABLE 219            ECMO MACHINES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY REGION AND APPLICATION   195

TABLE 220            ECMO MACHINES MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–SEPTEMBER 2025                198

TABLE 221            ECMO MACHINES MARKET: DEALS, JANUARY 2021–SEPTEMBER 2025   199

TABLE 222            ECMO MACHINES MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025                199

TABLE 223            GETINGE: COMPANY OVERVIEW              200

TABLE 224            GETINGE: PRODUCTS OFFERED               201

TABLE 225            GETINGE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2025   202

TABLE 226            GETINGE: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025              202

TABLE 227            MEDTRONIC: COMPANY OVERVIEW       204

TABLE 228            MEDTRONIC: PRODUCTS OFFERED        206

TABLE 229            TERUMO CORPORATION: COMPANY OVERVIEW          208

TABLE 230            TERUMO CORPORATION: PRODUCTS OFFERED                 210

TABLE 231            TERUMO CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2025   210

TABLE 232            TERUMO CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2025                211

TABLE 233            FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW          212

TABLE 234            FRESENIUS MEDICAL CARE AG: PRODUCTS OFFERED             213

TABLE 235            FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2021–SEPTEMBER 2025                214

TABLE 236            LIVANOVA PLC: COMPANY OVERVIEW  215

TABLE 237            LIVANOVA PLC: PRODUCTS OFFERED   217

TABLE 238            NIPRO: COMPANY OVERVIEW   219

TABLE 239            NIPRO: PRODUCTS OFFERED    220

TABLE 240            WEIGAO GROUP CO., LTD.: COMPANY OVERVIEW          221

TABLE 241            WEIGAO GROUP CO., LTD.: PRODUCTS OFFERED             223

TABLE 242            ABBOTT: COMPANY OVERVIEW                224

TABLE 243            ABBOTT: PRODUCTS OFFERED 225

TABLE 244            ABBOTT: PRODUCT APPROVALS, JANUARY 2021–SEPTEMBER 2025   226

TABLE 245            MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW   227

TABLE 246            MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED    228

TABLE 247            EUROSETS: COMPANY OVERVIEW           229

TABLE 248            EUROSETS: PRODUCTS OFFERED            229

TABLE 249            SPECTRUM MEDICAL: COMPANY OVERVIEW                 230

TABLE 250            SENKO MEDICAL INSTRUMENT MFG. CO., LTD.: COMPANY OVERVIEW   231

TABLE 251            CHALICE MEDICAL LTD.: COMPANY OVERVIEW                 232

TABLE 252            MAGASSIST CO., LTD.: COMPANY OVERVIEW                 233

TABLE 253            BRAILE BIOMÉDICA: COMPANY OVERVIEW                 234

TABLE 254            GIZMOMED PRIVATE LIMITED: COMPANY OVERVIEW          235

TABLE 255            ORIGEN BIOMEDICAL, INC.: COMPANY OVERVIEW          236

TABLE 256            ABIOMED: COMPANY OVERVIEW             236

TABLE 257            ANDOCOR: COMPANY OVERVIEW           237

TABLE 258            JIANGSU STMED TECHNOLOGY CO., LTD.: COMPANY OVERVIEW   238

TABLE 259            CARDIOQUIP: COMPANY OVERVIEW      238

TABLE 260            CBM LIFEMOTION: COMPANY OVERVIEW                 239

TABLE 261            CHANGZHOU KANGXIN MEDICAL INSTRUMENTS: COMPANY OVERVIEW  240

TABLE 262            GENTHERM: COMPANY OVERVIEW         241

LIST OF FIGURES

FIGURE 1              ECMO MACHINES MARKET SEGMENTATION AND REGIONAL SCOPE 26

FIGURE 2              ECMO MACHINES MARKET: RESEARCH DESIGN                 31

FIGURE 3              PRIMARY SOURCES         33

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE

AND DEMAND-SIDE PARTICIPANTS        35

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY-SIDE):

BY COMPANY TYPE, DESIGNATION, AND REGION            36

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE):

BY END USER, DESIGNATION, AND REGION        36

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         37

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION OF GETINGE AB, 2024            38

FIGURE 9              ECMO MACHINES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION, 2024               39

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS, 2025–2030  40

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 41

FIGURE 12            ECMO MACHINES MARKET: TOP-DOWN APPROACH         41

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 43

FIGURE 14            ECMO MACHINES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)                45

FIGURE 15            ECMO MACHINES MARKET, BY MODALITY, 2025 VS. 2030 (USD MILLION)                46

FIGURE 16            ECMO MACHINES MARKET, BY PATIENT TYPE, 2025 VS. 2030 (USD MILLION)      46

FIGURE 17            ECMO MACHINES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)      47

FIGURE 18            ECMO MACHINES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)                47

FIGURE 19            GEOGRAPHICAL SNAPSHOT OF ECMO MACHINES MARKET       48

FIGURE 20            GROWING DEMAND FOR INTEGRATED MULTIFUNCTIONAL DEVICES AND EXPANDING ACCESS TO ADVANCED ICUS IN UNDERSERVED REGIONS TO DRIVE MARKET GROWTH          49

FIGURE 21            COMPONENTS SEGMENT TO ACCOUNT FOR LARGEST SHARE

OF APAC MARKET IN 2024             50

FIGURE 22            INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       51

FIGURE 23            NORTH AMERICA TO DOMINATE ECMO MACHINES MARKET       51

FIGURE 24            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH

DURING FORECAST PERIOD       52

FIGURE 25            ECMO MACHINES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES         53

FIGURE 26            ECMO MACHINES MARKET: TRENDS/DISRUPTIONS

IMPACTING CUSTOMERS’ BUSINESSES 58

FIGURE 27            AVERAGE SELLING PRICE TREND OF ECMO MACHINES,

BY REGION, 2022–2024 (USD)      59

FIGURE 28            VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND DISTRIBUTION PHASES 60

FIGURE 29            ECMO MACHINES MARKET: SUPPLY CHAIN ANALYSIS            63

FIGURE 30            ECMO MACHINES MARKET: ECOSYSTEM ANALYSIS            63

FIGURE 31            ECMO MACHINES MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2023 65

FIGURE 32            ECMO MACHINES MARKET: VALUE OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023            65

FIGURE 33            ECMO MACHINES MARKET: NUMBER OF INVESTOR DEALS,

BY KEY PLAYER, 2019–2023 (USD MILLION)           66

FIGURE 34            ECMO MACHINES MARKET: PATENT ANALYSIS, JANUARY 2015−JULY 2025             70

FIGURE 35            ECMO MACHINES MARKET: PORTER’S FIVE FORCES ANALYSIS           81

FIGURE 36            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP TWO PRODUCTS         83

FIGURE 37            KEY BUYING CRITERIA FOR TOP TWO PRODUCTS         84

FIGURE 38            NORTH AMERICA: ECMO MACHINES MARKET SNAPSHOT          125

FIGURE 39            ASIA PACIFIC: ECMO MACHINES MARKET SNAPSHOT          150

FIGURE 40            REVENUE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET, 2020–2024 (USD MILLION) 186

FIGURE 41            MARKET SHARE ANALYSIS OF KEY PLAYERS IN ECMO MACHINES MARKET (2024)             187

FIGURE 42            ECMO MACHINES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024         189

FIGURE 43            ECMO MACHINES MARKET: COMPANY FOOTPRINT       190

FIGURE 44            ECMO MACHINES MARKET: COMPANY EVALUATION

MATRIX (STARTUPS/SMES), 2024               194

FIGURE 45            EV/EBITDA OF KEY VENDORS   196

FIGURE 46            YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA

OF KEY VENDORS            196

FIGURE 47            ECMO MACHINES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS            197

FIGURE 48            GETINGE: COMPANY SNAPSHOT              201

FIGURE 49            MEDTRONIC: COMPANY SNAPSHOT      205

FIGURE 50            TERUMO CORPORATION: COMPANY SNAPSHOT          209

FIGURE 51            FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT          213

FIGURE 52            LIVANOVA PLC: COMPANY SNAPSHOT 216

FIGURE 53            NIPRO: COMPANY SNAPSHOT   220

FIGURE 54            WEIGAO GROUP CO., LTD.: COMPANY SNAPSHOT          222

FIGURE 55            ABBOTT: COMPANY SNAPSHOT                225

FIGURE 56            MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT   228

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧